Elanco Animal Health Incorporated (ELAN) |
|
26.27 0.73 (2.86%)
|
11-19 16:03 |
|
Open: |
25.71 |
Pre. Close: |
25.54 |
|
High:
|
26.64 |
Low:
|
25.48 |
|
Volume:
|
6,123,993 |
Market Cap:
|
9799M |
|
|
|
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
26.663 - 26.851 |
26.851 - 26.997 |
|
Low:
|
25.146 - 25.341 |
25.341 - 25.493 |
|
Close:
|
26.032 - 26.338 |
26.338 - 26.576 |
|
Technical analysis |
as of: 2019-11-19 4:25:52 PM |
|
Overall:
|
  |
| Stoxline posted a STRONG BUY today, upgraded from lower rating. Upward movement to be expected. |
| Target: |
Six months: 31.33 One year: 32.47 |
| Support: |
Support1: 25.25 Support2: 21.01 |
| Resistance: |
Resistance1: 26.83 Resistance2: 27.80 |
| Pivot: |
26.61  |
| Moving Average: |
MA(5): 25.85 MA(20): 26.64
MA(100): 28.78 MA(250): 30.56 |
| MACD: |
MACD(12,26): -0.27 Signal(9): -0.18 |
| Stochastic oscillator: |
%K(14,3): 28.63 %D(3): 18.95 |
| RSI: |
RSI(14): 47.32 |
| 52-week: |
High: 35.46 Low: 25.25 Change(%): -20.6 |
| Average Vol(K): |
3-Month: 388574 10-Days: 578107 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.ELAN has closed above bottom band by 37.9%. Bollinger Bands are 17.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
2019-11-15
Elanco Animal Health (NYSE:ELAN) Sets New 1-Year Low at $25.43
Elanco Animal Health (NYSE:ELAN)’s stock price hit a new 52-week low during mid-day trading on Thursday . The stock traded as low as $25.43 and last traded at $25.70, with a volume of 97899 shares traded. The stock had previously closed at $26.00. ELAN has been the subject of several recent research reports. Cleveland Research […]
2019-11-07
Morgan Stanley Upgrades Elanco Animal Health On Valuation
While Elanco Animal Health Inc’s (NYSE: ELAN ) current valuation reflects the ongoing investor concerns, the focus is now likely to shift to the positives related to the Bayer transaction, prospects of margin expansion and long-term pipeline potential over 20202, according to Morgan Stanley. The Analyst Morgan Stanley’s David Risinger upgraded Elanco Animal Health from Equal-Weight to Overweight while reducing the price target from $34 to $32. The Thesis Elanco Animal Health’s shares have declined by 15% year to date, significantly underperforming the broader market and key competitor Zoetis Inc (NYSE: ZTS ), Risinger said in the note. Investors currently appear skeptical about the decision … Full story available on Benzinga.com
|
Financial Analysis |
| Growth |
NA |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
NA |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
NA |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
NA |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
